Evidence map›Paper›PMID 35747231›Full record

ArticleERJ open research2022

Impact of wait times for treatment on clinical outcomes in patients with obstructive sleep apnoea: protocol for a randomised controlled trial.

Christina S Thornton, Marcus Povitz, Willis H Tsai, Andrea H Loewen, Ada Ip-Buting, Tetyana Kendzerska, W Ward Flemons, Kristin L Fraser, Patrick J Hanly, Sachin R Pendharkar

Open access · goldAbstract read
In one paragraph

Article in ERJ open research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Christina S ThorntonDept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Marcus PovitzDept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Willis H TsaiDept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Andrea H LoewenDept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Ada Ip-ButingDept of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, Canada.ORCID https://orcid.org/0000-0002-6262-5482
Tetyana KendzerskaDept of Medicine, Faculty of Medicine, University of Ottawa and Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada.ORCID https://orcid.org/0000-0002-5301-1796
W Ward FlemonsDept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Kristin L FraserDept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Patrick J HanlyDept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Sachin R PendharkarDept of Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
University of Calgary · CAUniversity of Ottawa · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Obstructive sleep apnoea (OSA) is a common chronic condition that is associated with significant morbidity and economic cost. Prolonged wait times are increasingly being recognised as a barrier to diagnosis and treatment of many chronic diseases; however, no study to date has prospectively evaluated the impact of wait times on health outcomes in OSA. Objective: The purpose of this study is to determine whether treatment outcomes for individuals with OSA differ between patients managed using an expedited Methods: A pragmatic randomised controlled trial design will be used with a target sample size of 200 adults. Participants with clinically significant uncomplicated OSA will be recruited through referrals to a large tertiary care sleep centre (Calgary, AB, Canada) and randomised to either early management (within 1 month) or usual care (∼6 months) with a 1:1 allocation using a concealed computer-generated randomisation sequence. The primary outcome will be adherence to positive airway pressure (PAP) therapy at 3 months after treatment initiation. Secondary outcomes will include change in sleepiness, quality of life, patient satisfaction, and patient engagement with therapy from baseline to 3 months after PAP initiation, measured using validated questionnaires and qualitative methods. Anticipated results: This study will determine whether expedited care for OSA leads to differences in PAP adherence and/or patient-reported outcomes. More broadly, the findings of this study may improve the understanding of how wait time reductions impact health outcomes for other chronic diseases.

Identifiers

PMID35747231
PMCPMC9209848
OpenAlexW4282959803

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.